Carregant...
Novel Immunotherapies for Multiple Myeloma
PURPOSE OF REVIEW: The treatment landscape of multiple myeloma is rapidly changing; however, despite improvement in patients’ survival, it still remains a largely incurable disease. One hallmark of myeloma is substantial immune dysfunction leading to an increased infection rate and the inability of...
Guardat en:
| Publicat a: | Curr Hematol Malig Rep |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5693669/ https://ncbi.nlm.nih.gov/pubmed/28819882 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11899-017-0397-7 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|